However, combined CAP exposure for 30 s or 40 s with BTZ at doses of 3 nM and 5 nM for 24 h remarkably reduced MM cell survival, with respect to either CAP exposure or BTZ administration alone. This evidence concerns the gene CASC3 and Miyoshi myopathy.